| ID | 1651 |
|---|
| No | 1651 |
|---|
| Brand Name | LORANIB |
|---|
| Ingredients | LORLATINIB 25 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 30'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE OR ROSI POSITIVE METASTATIC NON SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON IN WHICHTHE DISEASE OF KIA HAS SPREAD TO THE STAGE |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | WHITE,ROUND TABLET. |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 L 0935/22 |
|---|
| FDD Registration Date | 06/12/2022 |
|---|
| Expiry Date | 05/12/2025 |
|---|
